Could a simple infusion during surgery stop pain before it starts?

NCT ID NCT07676942

First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This study investigates whether giving lidocaine or dexmedetomidine through a vein during urethral reconstruction surgery can lower pain right after surgery and reduce the chance of chronic pain lasting months later. About 80 adults scheduled for this surgery will receive one of the two drugs or a placebo. The goal is to see if these well-known, safe medications can improve recovery and prevent long-term pain.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
lidocaine and dexmedetomidine
What this could lead to
If effective, these well-known drugs could become a standard way to prevent long-term pain after urethral surgery, reducing opioid use.
What could go wrong
This is a small, early-stage trial. The drugs may not reduce chronic pain more than placebo, and side effects like low blood pressure or slow heart rate are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for URETHRAL STRICTURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Anesthesiology and Intensive Care, Centre of Postgraduate Medical Education

    Warsaw, 01-355, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.